Abstract Purpose of Review Prostate cancer (PCa) is amongst the most common cancers in
men worldwide. Cardiovascular (CV) risk factors and CV disease (CVD) are common …

Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial
infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary …

Background Prostate-specific membrane antigen (PSMA)-PET was introduced into clinical
practice in 2012 and has since transformed the staging of prostate cancer. Prostate Cancer …

Purpose Little is known about the detailed spectrum of the cause of death associated with
prostate cancer (PCa). This study systematically characterized the cause of death among …

Background Cardiovascular disease (CVD) incidence is higher in men with prostate cancer
(PC) than without. Objectives We describe the rate and correlates of poor cardiovascular risk …

Background There are limited data on the physical effects of androgen deprivation therapy
(ADT) for prostate cancer (PC), and on the relationships of such measures of adiposity and …

Background Racial/ethnic disparities in prostate cancer are reported in the United States
(US). However, long-term trends and contributors of racial/ethnic disparities in all-cause and …

Background Active surveillance (AS) is standard care for most men with low-risk prostate
cancer (PC); yet, many men on AS eventually undergo curative therapy. Interventions to …

Background The prevalence of cardiovascular risk factors and disease is high in patients
with newly diagnosed prostate cancer (PC). Survivorship of PC patients is often determined …

Purpose The risk of cardiovascular disease (CVD) mortality in patients with localized
prostate cancer (PCa) by risk stratification remains unclear. The aim of this study was to …